A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053 AM1)
| Status: | Archived |
|---|---|
| Conditions: | Osteoporosis |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2010 |
| End Date: | May 2014 |
A Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) in the Treatment of Men With Osteoporosis Treated With Vitamin D and Calcium
The purpose of this study is to test the hypothesis that treatment with odanacatib will
result in increased BMD (bone mineral density) compared to treatment with placebo. This
study will also evaluate the safety and efficacy of odanacatib for male osteoporosis
patients.
The original study was divided into two parts, with the primary analysis of endpoints to
occur at 24 months and the patients will then remain in the study for an additional 12
months (Part 2). Amendment 1 of the protocol removed the additional 12 month period and the
Month 36 BMD analysis was deleted.
We found this trial at
9
sites
Click here to add this to my saved trials
Abington Memorial Hospital Abington Memorial Hospital (AMH) is a 665-bed, regional referral center and teaching...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials